Medical News

RSS

TheraQuest launches new analgesic product pipeline

TheraQuest Biosciences, Inc., a clinical stage pain management company today unveiled its analgesic product pipeline. TheraQuest also announced the launch of its new corporate website at http://www.theraquestinc.com.

23 Jun 2010

Certification rule opens door for health IT vendors, but other regs lag

A final regulation for a temporary program to certify organizations to sell health IT systems will be published Thursday in the Federal Register, NextGov reports. "Certification is important because it gives health care providers the confidence that products will function properly, meet meaningful use criteria and improve quality of care, the article states.

23 Jun 2010

Survey: MegaRed Omega-3 Krill Oil recommended for overall cardiovascular health

With America focused on the future of healthcare, a recent survey provides Americans added confidence in the ability of supplements like MegaRed Omega-3 Krill Oil to support their overall cardiovascular health.

23 Jun 2010

BGU researchers develop software program to detect depression in blogs, online texts

Researchers at Ben-Gurion University of the Negev (BGU) developed a software program that can detect depression in blogs and online texts. The software is capable of identifying language that can indicate the writer's psychological state, which could serve as a screening tool.

23 Jun 2010

Obama warns health insurers against using reform to boost premium rates, unveils new patient bill of rights

Today, during an address in the East Room of the White House following a meeting with executives of leading health insurance companies and state insurance commissioners, "President Barack Obama warned insurance firms … not to use his healthcare overhaul as an opportunity to enact big rate increases and said the federal government would work with states to monitor them."

23 Jun 2010

Phase I/II clinical trials show crizotinib reduces lung cancer tumors

Patients with a specific kind of lung cancer may benefit from a Phase III clinical trial offered by the Moores UCSD Cancer Center. The new drug, crizotinib, under development by Pfizer, showed dramatic results in reducing lung cancer tumors in some patients during Phase I and II clinical trials.

23 Jun 2010

Superficial relationships lead to feelings of detachment, health-related problems

Hoarding friends on Facebook - or followers on Twitter - won't do much to stave off loneliness if those relationships lack any kind of strong connection, new research finds.

23 Jun 2010

Mayo Clinic, University of Illinois announce strategic alliance for technology-based health care

Mayo Clinic and the University of Illinois at Urbana-Champaign are announcing a strategic alliance designed to promote a broad spectrum of collaborative research, development of new technologies and clinical tools, and design and implementation of novel education programs. Both parties recently signed an agreement establishing the formal relationship.

23 Jun 2010

Budget chief Orszag reportedly set to resign

Peter Orszag, director of the Office of Management and Budget, will step down from his post in July, "according to two knowledgeable administration officials," The Wall Street Journal reports.

23 Jun 2010

GHX cuts over $155.6M in healthcare costs during first-quarter

GHX and its participating suppliers and providers are on target to cut a total of $5 billion in healthcare costs in the next 5 years by improving supply chain efficiencies, visibility and trading partner collaboration. GHX provides technology and services to automate and optimize business processes throughout the healthcare supply chain, and has achieved its first-quarter goal of cutting more than $155.6 million in healthcare costs.

23 Jun 2010

New survey: Consumers who buy their own health insurance report big rate increase requests

"Wellpoint - a big health insurer sharply criticized by the Obama Administration for seeking to raise rates up to 39 percent for some California policyholders earlier this year - was not unusual in seeking double-digit increases, a new survey finds" (Appleby and Schiff, 6/21).

23 Jun 2010

Exercise alone without creatine supplements helps in cardiac rehabilitation

Athletes have been enjoying the benefits of creatine supplements to gain stronger muscles since the 1990s, and the supplement has also proven beneficial among other groups. Could it help cardiac patients regain strength to help with their heart-training workouts as part of rehabilitation? The evidence at this stage suggests not - exercise alone proved a far more powerful tonic for patients in a study out today. The results appear in the journal Clinical Rehabilitation, published by SAGE.

23 Jun 2010

Local health clinics in U.S. do not offer diabetes screening, obesity prevention programs to poor clients: Study

A new nationwide study finds that some local health clinics do not offer diabetes screening or obesity prevention programs to their clients, who tend to be poor. The clinics need to be "armed and equipped" to respond to the growing threat from type 2 diabetes and obesity in the United States, said researcher and study co-author Ann Albright. "These are huge problems that we're facing. We want to be sure that we're responding effectively."

23 Jun 2010

Mice treated with XOMA 052 experiences improvement in measures associated with diabetes: Endocrinology

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced the publication of data from a mouse model of diet-induced obesity in the June, 2010 edition of the journal Endocrinology. The data showed that mice treated with XOMA 052 both prophylactically and therapeutically experienced improvement in measures associated with diabetes and cardiovascular disease including reduction in glycosylated hemoglobin levels, improvement in glucose control, improved beta-cell survival and function, and a reduction in total cholesterol without reduction in high density lipoprotein.

23 Jun 2010

Insuring your health: Rising costs spur increase in health savings accounts

In this Kaiser Health News consumer column, Michelle Andrews writes: "High-deductible health plans and the health savings accounts (HSAs) that link to them are becoming a familiar fixture on the insurance landscape, even though they get mixed reviews from many consumers and health-policy experts" (Andrews, 6/22).

23 Jun 2010

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Cell>Point announced today that it has submitted to the Food and Drug Administration an Investigational New Drug (IND) application for a Phase 1b/2 trial of its 99mTc-EC-G diagnostic in assessing patients with Coronary Artery Disease (CAD).

23 Jun 2010

Medicare physician payment cuts could cost millions more in reprocessing

Politico reports that the fight over a "doc fix" — fixing the Medicare reimbursement rate for doctors — is "straining not just doctors but also House-Senate relations" and could cost taxpayers millions of dollars. "Having waited for weeks in hopes of a stay, the Centers for Medicare & Medicaid Services, or CMS, is now enforcing a 21 percent cut in physician payments, and an estimated 50 million claims, held back since June 1, will be the first affected."

23 Jun 2010

IMUC signs exclusive licensing agreement with Targepeutics for acquisition of IL-13Ra2 receptor

ImmunoCellular Therapeutics, a clinical-stage biotechnology company focused on developing new immune-based products to treat cancer, today announced it has entered into an exclusive licensing agreement with Targepeutics, Inc. for ImmunoCellular's acquisition of Targepeutics' worldwide intellectual property rights surrounding the IL-13 receptor, alpha 2.

23 Jun 2010

Study investigates benefits of filtering blood to create safer approaches to transfusion therapy

Researchers at the University of Rochester Medical Center have discovered yet another reason to filter the foreign white cells from donor blood: The resulting blood product is associated with dramatically fewer cardiopulmonary complications for patients who received a transfusion.

23 Jun 2010

FDA grants Tolera's TOL101 orphan drug designation for treatment of T1DM

Tolera Therapeutics, Inc., was granted orphan drug status by the United States Food and Drug Administration (FDA) for TOL101 (anti-TCR murine monoclonal antibody, type IgM), for treatment of recent onset immune-mediated Type 1 diabetes mellitus (T1DM). Designation is granted for treatment of patients sixteen years of age and younger with immune-mediated T1DM and preserved pancreatic beta-cell function, commonly referred to as juvenile diabetes.

23 Jun 2010

Medical News

TheraQuest launches new analgesic product pipeline

Certification rule opens door for health IT vendors, but other regs lag

Survey: MegaRed Omega-3 Krill Oil recommended for overall cardiovascular health

BGU researchers develop software program to detect depression in blogs, online texts

Obama warns health insurers against using reform to boost premium rates, unveils new patient bill of rights

Phase I/II clinical trials show crizotinib reduces lung cancer tumors

Superficial relationships lead to feelings of detachment, health-related problems

Mayo Clinic, University of Illinois announce strategic alliance for technology-based health care

Budget chief Orszag reportedly set to resign

GHX cuts over $155.6M in healthcare costs during first-quarter

New survey: Consumers who buy their own health insurance report big rate increase requests

Exercise alone without creatine supplements helps in cardiac rehabilitation

Local health clinics in U.S. do not offer diabetes screening, obesity prevention programs to poor clients: Study

Mice treated with XOMA 052 experiences improvement in measures associated with diabetes: Endocrinology

Insuring your health: Rising costs spur increase in health savings accounts

Cell>Point submits IND application for Phase 1b/2 99mTc-EC-G diagnostic trial in assessing CAD patients

Medicare physician payment cuts could cost millions more in reprocessing

IMUC signs exclusive licensing agreement with Targepeutics for acquisition of IL-13Ra2 receptor

Study investigates benefits of filtering blood to create safer approaches to transfusion therapy

FDA grants Tolera's TOL101 orphan drug designation for treatment of T1DM

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Latest News